Staging and Outcome Depending on Surgical Treatment in Adenocarcinomas of the Oesophagogastric Junction
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01766986|
Recruitment Status : Completed
First Posted : January 11, 2013
Last Update Posted : November 18, 2014
Background: Owing to controversial staging and classification of adenocarcinoma of the oesophagogastric junction (AOG) before surgery, the choice of appropriate surgical approach remains problematic.
In a retrospective study, preoperative staging of AOG and the impact of preoperative misclassification on outcome were analysed. Methods: Data from patients with AOG were analysed from a prospectively collected database with regard to surgical treatment, preoperative and postoperative staging, and outcome.
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||130 participants|
|Official Title:||Staging and Outcome Depending on Surgical Treatment in Adenocarcinomas of the Oesophagogastric Junction|
|Study Start Date :||January 2008|
|Actual Primary Completion Date :||January 2013|
|Actual Study Completion Date :||January 2013|
- Overall survival [ Time Frame: 60 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01766986
|Study Chair:||Jakob R Izbicki, MD.||University Hospital Hamburg-Eppendof, Hamburg, Germany|